Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M16,440Revenue $M13,302Net Margin (%)3.4Altman Z-Score2.1
Enterprise Value $M23,975EPS $2.1Operating Margin %9.8Piotroski F-Score4
P/E(ttm)36.9Beneish M-Score-2.6Pre-tax Margin (%)6.5Higher ROA y-yN
Price/Book3.210-y EBITDA Growth Rate %15.1Quick Ratio2.0Cash flow > EarningsY
Price/Sales1.25-y EBITDA Growth Rate %15.2Current Ratio2.1Lower Leverage y-yN
Price/Free Cash Flow29.1y-y EBITDA Growth Rate %-19.0ROA % (ttm)2.5Higher Current Ratio y-yY
Dividend Yield %--PEG2.4ROE % (ttm)9.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M215ROIC % (ttm)7.2Gross Margin Increase y-yN

Gurus Latest Trades with DVA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DVAArnold Van Den Berg 2015-06-30 Reduce-0.11%$79.47 - $84.23
($82.11)
$ 76.29-7%Reduce 5.86%153,928
DVAMario Gabelli 2015-06-30 Add$79.47 - $84.23
($82.11)
$ 76.29-7%Add 5.29%41,763
DVAArnold Van Den Berg 2015-03-31 Buy 1.87%$72.78 - $82.84
($76.74)
$ 76.29-1%New holding163,503
DVASteve Mandel 2015-03-31 Add0.47%$72.78 - $82.84
($76.74)
$ 76.29-1%Add 38.47%5,455,774
DVAJoel Greenblatt 2015-03-31 Sold Out -0.22%$72.78 - $82.84
($76.74)
$ 76.29-1%Sold Out0
DVAMario Gabelli 2015-03-31 Reduce$72.78 - $82.84
($76.74)
$ 76.29-1%Reduce 7.25%39,663
DVASteve Mandel 2014-12-31 Buy 1.3%$72.03 - $78.07
($75.35)
$ 76.291%New holding3,940,169
DVAJoel Greenblatt 2014-12-31 Add0.16%$72.03 - $78.07
($75.35)
$ 76.291%Add 240.25%352,562
DVAMario Gabelli 2014-12-31 Reduce-0.03%$72.03 - $78.03
($75.28)
$ 76.291%Reduce 63.03%42,763
DVASteve Mandel 2014-06-30 Sold Out -1.1%$67.12 - $72.95
($69.49)
$ 76.2910%Sold Out0
DVAJoel Greenblatt 2014-06-30 Reduce-0.11%$67.12 - $72.95
($69.49)
$ 76.2910%Reduce 49.01%110,765
DVAMario Gabelli 2014-06-30 Add0.03%$67.12 - $72.95
($69.49)
$ 76.2910%Add 330.08%114,328
DVASteve Mandel 2014-03-31 Reduce-1.31%$62.74 - $69.81
($66.3)
$ 76.2915%Reduce 56.84%3,655,739
DVAMario Gabelli 2014-03-31 Buy 0.01%$62.74 - $69.81
($66.3)
$ 76.2915%New holding26,583
DVASteve Mandel 2013-12-31 Add0.59%$55.03 - $63.39
($58.62)
$ 76.2930%Add 34.41%8,470,777
DVAWarren Buffett 2013-12-31 Add0.3%$55.03 - $63.39
($58.62)
$ 76.2930%Add 15.95%36,461,294
DVAJoel Greenblatt 2013-12-31 Add0.21%$55.03 - $63.39
($58.62)
$ 76.2930%Add 171.10%221,775
DVARon Baron 2013-12-31 Sold Out -0.16%$55.03 - $63.39
($58.62)
$ 76.2930%Sold Out0
DVAJulian Robertson 2013-09-30 Sold Out -1.9%$53.755 - $60.615
($57.24)
$ 76.2933%Sold Out0
DVASteve Mandel 2013-09-30 Buy 1.6%$53.755 - $60.615
($57.24)
$ 76.2933%New holding6,302,027
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DVA is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DVA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DAVIDSON CAROL ANTHONYDirector 2015-08-17Sell4,038$79.93-4.55view
JIGANTI JEANINE MARIEChief Compliance Officer 2015-08-10Sell1,311$81.32-6.19view
BERG CHARLESDirector 2015-08-06Sell11,636$81.01-5.83view
Margolis Robert JCo-Chairman of the Board 2015-06-04Sell31,400$83.39-8.51view
STAFFIERI MICHAEL DAVIDCOO, Kidney Care 2015-05-28Sell9,050$84.07-9.25view
Mildenberger LauraChief People Ofcr, Kidney Care 2015-05-20Sell9,579$83.15-8.25view
Margolis Robert JCo-Chairman of the Board 2015-05-19Sell31,400$82.73-7.78view
HILGER JAMES KInterim CFO & CAO 2015-05-18Sell3,983$82.1-7.08view
Kogod DennisCOO, HealthCare Partners 2015-05-18Sell36,466$82.5-7.53view
STAFFIERI MICHAEL DAVIDCOO, Kidney Care 2015-05-18Sell2,047$82.03-7view

Press Releases about DVA :

Quarterly/Annual Reports about DVA:

News about DVA:

Articles On GuruFocus.com
Starting With GAAP Jun 11 2015 
One Jun 09 2015 
One Jun 09 2015 
Berkshire Hathaway: Business Value Exceeds Market Value May 26 2015 
Manning & Napier's Top 5 Stock Selections of Q1 Apr 21 2015 
A Further Peek Into Ted Weschler’s Thought Process Apr 21 2015 
Texas Investor Arnold Van Den Berg Purchases 5 Stocks in Q1 Apr 14 2015 
Andreas Halvorsen Keeps Buying DVA, HLT, ACT Apr 10 2015 
A Peek into Ted Weschler’s Thought Process Mar 20 2015 
Seven Subscribers Win Contest to Name Buffett's Stock Buys in Fourth Quarter Mar 08 2015 

More From Other Websites
Mid-cap Healthcare Stocks The Smart Money Is Crazy About Aug 29 2015
Dinesh Kumar Named Senior VP of Clinical Transformation at DaVita HealthCare Partners Aug 26 2015
Dinesh Kumar Named Senior VP of Clinical Transformation at DaVita HealthCare Partners Aug 26 2015
DaVita (DVA) to Purchase Renal Ventures for $415M Aug 25 2015
DaVita Healthcare to Buy Renal Ventures for $415 Million Aug 24 2015
DaVita HealthCare Partners to Acquire Renal Ventures Aug 24 2015
DaVita HealthCare Partners to Acquire Renal Ventures Aug 24 2015
Community Health and Disaster Preparedness Fair Being Held in Colorado Springs Aug 18 2015
Community Health and Disaster Preparedness Fair Being Held in Colorado Springs Aug 18 2015
DaVita hires president for Colorado managed-care division Aug 12 2015
DAVITA HEALTHCARE PARTNERS INC. Financials Aug 11 2015
10-Q for DaVita HealthCare Partners, Inc. Aug 08 2015
AmSurg Tops Q2 Earnings on High Revenues, Raises Outlook - Analyst Blog Aug 05 2015
DaVita Beats Q2 Earnings Estimates, Updates 2015 Guidance - Analyst Blog Aug 05 2015
DAVITA HEALTHCARE PARTNERS INC. Files SEC form 10-Q, Quarterly Report Aug 05 2015
Edited Transcript of DVA earnings conference call or presentation 4-Aug-15 9:00pm GMT Aug 04 2015
DaVita reports 'solid' quarter despite whistle-blower settlement Aug 04 2015
DaVita HealthCare Partners Inc Earnings Call scheduled for 5:00 pm ET today Aug 04 2015
DaVita HealthCare tops Street 2Q forecasts Aug 04 2015
DaVita HealthCare tops Street 2Q forecasts Aug 04 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK